In 2023, Roche said it was removing TNKase for stroke from its phase 3 programmes after a readout of the TIMELESS trial, but ...

February is American Heart Month. And what better time to talk about heart health? Did you know heart disease claims a life ...

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...

A new Georgetown University Medical Center study exploring a new brain imaging technique is bringing stroke experts a step ...

Divorce can be painful for children of separating parents, but new research out of the University of Texas at Arlington ...

Sotagliflozin also can significantly reduce the rate of myocardial infarction and stroke compared with placebo.

A new Georgetown University Medical Center study in collaboration with MedStar Health and the National Institutes of Health exploring a new brain imaging technique is bringing stroke experts a step ...

Older adults who are admitted to the hospital with their first ischemic stroke who have poor nutritional status upon admission have a higher risk of post-stroke myocardial injury, a study shows.

Johnson & Johnson MedTech issued a recall for its Biosense Webster Varipulse Bi-Directional Ablation Catheter following reports of strokes and transient ischemic attacks in patients undergoing ...

FDA approval was based on the AcT noninferiority trial that found tenecteplase (at 0.25 mg/kg) to be at least on par with alteplase for safety and efficacy in acute ischemic stroke in Canadians ...

From a certain high-heeled Mouse to the tiny version of our favorite candy, just the idea of "mini" is psychologically ...

In recognition of Brain Health Awareness Week, which runs from March 10-16, Jamaica Hospital Medical Center Neurosurgeon Dr.